Somatic amplification and addiction profile as risk factors for medication overuse headache with chronic migraine

Introduction Overuse of analgesics can lead to medication-overuse headache (MOH) in chronic migraine (CM) patients, and is often linked to addiction. This study explores the addiction-related characteristics and somatic amplification in patients with, CM with medication overuse headache (CM+MOH), CM...

Full description

Saved in:
Bibliographic Details
Published in:Neurological sciences 2024-11, Vol.45 (11), p.5375-5383
Main Authors: Cesur, Ender, Yavuz, Burcu Göksan, Acar, Erkan, Özdemir, Zeynep, Soyukibar, Tuba Erdoğan, Aydınlar, Elif Ilgaz
Format: Article
Language:English
Subjects:
Addictions
Analgesics
Drug use
Headache
Headaches
Medicine
Medicine & Public Health
Migraine
Neurology
Neuroradiology
Neurosurgery
Original
Original Article
Psychiatry
Risk factors
Substance use
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Overuse of analgesics can lead to medication-overuse headache (MOH) in chronic migraine (CM) patients, and is often linked to addiction. This study explores the addiction-related characteristics and somatic amplification in patients with, CM with medication overuse headache (CM+MOH), CM, and healthy controls. Methods 73 CM patients and 70 CM+MOH, along with 63 healthy controls, participated in the study. Assessments included a Sociodemographic Form, Migraine Disability Assessment Scale (MIDAS), Addiction Profile Index (API), Addiction Profile Index-Clinical Version (API-C), and the Somatosensory Amplification Scale (SSAS). Results Substance use characteristics, craving, motivation for use, and addiction severity scores were higher in the CM+MOH group than in both the CM and the control group. Specifically, the SSAS scores within the CM+MOH group surpassed those of both the CM and control groups. In the CM+MOH group, SSAS scores were a strong predictor of the amount of analgesic usage. Besides, craving and motivation for substance use scores significantly predicted the number of days analgesic taken per month in the CM+MOH group Conclusion CM patients with MOH exhibit a pronounced association with addiction, and a heightened manifestation of somatic symptoms. Addressing addiction characteristics and psychosomatic amplification is important to ensure comprehensive management.
ISSN:1590-1874
1590-3478
1590-3478
DOI:10.1007/s10072-024-07639-w